Dottikon ES Holding AG (0ACK)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 280.75 |
|---|---|
| 52-week range | 253.00 – 395.00 |
| Return, 1 month / 3 months | +8.9% / +6.7% |
| Return, 1 year / 3 years | −13.1% / +44.3% |
| Trend | Below its 200-day average |
| RSI (14) | 67 |
| Volatility (1 year) | 33.2% |
| Worst drawdown (1 year) | -34.9% |
| Average daily value traded | 0.11M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dottikon ES Holding is a Swiss specialty chemicals company based in Dottikon. It makes chemical intermediates and active ingredients for pharmaceutical and agrochemical customers, working largely as a contract manufacturer that carries out custom synthesis and exclusive synthesis for other firms. Its services cover the development and production of complex molecules, including hazardous chemistry and energetic materials, for clients in the life sciences and related industries.
On this site Dottikon ES Holding AG appears as a stock on the London Exchange (UK), code 0ACK, with prices in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dottikon ES Holding AG (0ACK) trades on the London Exchange in UK. It last closed at GBP 280.75 on 23 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 2,810 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.1% and over the last three months it rose 6.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.6% | ||
| From 52-week high | -28.0% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 6.7% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | -20.2% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.9% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +8.9% |
| 3 months | +6.7% |
| 6 months | −15.4% |
| 1 year | −13.1% |
| 3 years | +44.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 267.57 / 310.67 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.54 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.